Combined budesonide and antibiotic therapy for active Crohn’s disease: A randomized controlled trial

Gastroenterology

Volumn 123, Issue 1, 2002, Pages 33-40

  Steinhart, A Hillary ^a   Feagan, Brian G ^b   Wong, Cindy J ^b   Vandervoort, Margaret ^b   Mikolainis, Shelley ^a   Croitoru, Kenneth ^c   Seidman, Ernest ^d   Leddin, Desmond J ^e   Bitton, Alain ^f   Drouin, Eric ^d   Cohen, Albert ^g   Greenberg, Gordon R ^a  

^a MOUNT SINAI HOSPITAL   (United States)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f ROYAL VICTORIA HOSPITAL   (Canada)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; APO METRONIDAZOLE; BUDESONIDE; CIPROFLOXACIN; METRONIDAZOLE; PLACEBO;

ACNE; ADULT; AGITATION; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; COLON DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; CUSHING SYNDROME; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EDEMA; FATIGUE; FEMALE; FEVER; GLOSSITIS; HUMAN; ILEUM DISEASE; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; PANCREATITIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PURPURA; RANDOMIZED CONTROLLED TRIAL; RASH; REMISSION; TASTE DISORDER; TREATMENT OUTCOME; VAGINITIS; VERTIGO; WEIGHT REDUCTION;

EID: 0036305494     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.34225     Document Type: Article

References (33)

1. National Cooperative Crohn’s Disease Study: Results of drug treatment
2. Oral budesonide as maintenance treatment for Crohn’s disease: A placebo-controlled, dose-ranging study
3. A comparison of budesonide with prednisolone for active Crohn’s disease
4. A controlled double blind study of azathioprine in the management of Crohn’s disease
5. Methotrexate for the treatment of Crohn’s disease
6. Commensal bacteria as targets in Crohn’s disease
7. T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans
8. Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers
9. Intestinal inflammation and the gut microflora
10. The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn’s disease
11. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn’s disease and experimental colitis in vivo
12. Medical management of specific clinical presentations
13. Is there a role for antibiotics as primary therapy in Crohn’s ileitis?
14. How to do without steroids in inflammatory bowel disease
15. Inflammatory bowel disease
16. Antibiotics as therapeutic agents in Crohn’s disease
17. Development of a Crohn’s disease activity index - National Cooperative Crohn’s Disease Study
18. A new measure of health status for clinical trials in inflammatory bowel disease
19. Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease
20. A comparative study of metronidazole and sulfasalazine for active Crohn’s disease: The Cooperative Crohn’s Disease Study in Sweden
21. Antibiotic therapy for treatment in relapse of intestinal Crohn’s disease. A prospective randomized study
22. Double blind, placebo controlled trial of metronidazole in Crohn’s disease
23. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection
24. An antibiotic regimen for the treatment of active Crohn’s disease: A randomized, controlled clinical trial of metronidazole plus ciprofloxacin
25. Combination ciprofloxacin and metronidazole for active Crohn’s disease
26. The indigenous gastrointestinal microflora
27. Oral budesonide is as effective as oral prednisolone in active Crohn’s disease
28. A comparison of budesonide and mesalamine for active Crohn’s disease
29. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea
30. Drug-induced diarrhea
31. Metronidazole. A therapeutic review and update
32. Budesonide: An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis